Brind.

U-M startup commercializes histotripsy technology and offers specialized equipment to external researchers.

2 reports, 2 independent Updated Oct 6
Gone quiet
Reports
2
Developments
2
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

U-M startup commercializes histotripsy technology and offers specialized equipment to external researchers.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. U-M research team led by Zhen Xu regarding histotripsy, authorized by the FDA, continues with Grasso as Interim President.1 source
  2. U-M startup commercializes histotripsy technology developed by the Histotripsy Research Center.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped